EFFECT ·Filed Mar 4, 2026
IPO/offering going effective
Actionable Insight • Neutral
Traders should monitor for imminent pricing and offering details, which may introduce near-term volatility. The effectiveness creates potential for share dilution if a public offering follows, particularly relevant for the OTC-traded NVACW.
Final — all horizons settled through T+60d
PFSA ▼ -63.96% at T+60d
NEUTRAL call -63.96% · α vs SPY -74.05% · entry $0.9990 → $0.3600
T+1d
+1.10%
call +1.10% · α +1.67%
$1.01
settled 8mo ago
T+5d
-7.11%
call -7.11% · α -5.77%
$0.9280
settled 8mo ago
T+20d
-42.04%
call -42.04% · α -37.63%
$0.5790
settled 7mo ago
T+60d
-63.96%
call -63.96% · α -74.05%
$0.3600
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
Profusa, Inc. has announced the effectiveness of its SEC registration statement (File No. 333-293451), allowing the company to proceed with an offering of securities. The filing is an EFFECT notice, indicating that the registration is now active as of March 3, 2026.
Key Facts
- SEC Form EFFECT filed by Profusa, Inc. became effective on March 3, 2026.
- The registration statement (File No. 333-293451) is now effective, permitting the company to issue securities.
- This is not an IPO but likely a follow-on or shelf offering, given the company's prior existence and name change from NorthView Acquisition Corp in 2021.
- No specific offering size, price, or share count is disclosed in the EFFECT filing.
- Company operates in the medical devices sector (SIC 3841) and is headquartered in New York, NY.
Financial Impact
Not specified
dilutionequity capital
Risk Factors
- Potential for share dilution if a follow-on offering is executed.
- Uncertainty around offering size, timing, and use of proceeds.
- OTC listing may limit liquidity and increase volatility upon any offering.
Market Snapshot
Exchange
OTC
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000710 |
| Document: 9999999995-26-000710-index.html | 9999999995-26-000710 |
| Document: 9999999995-26-000710.txt | 9999999995-26-000710 |
20 reports for PFSA
67% Hit rate @ T+5 Went positive at some point 7 of 9 best @ T+20▲ +74.77%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G/A | $0.7650 | awaiting T+5 | — | $0.7800 (+1.96%) |
Oct 15, 2026 12d ago | Press Release | $1.07 $1.02 | ▼ −4.67% | ▼ −3.66% | $0.7800 (−27.10%) |
Oct 15, 2026 12d ago | 8-K | $1.07 $1.02 | ▲ +4.67% | ▲ +3.66% | $0.7800 (+27.10%) |
Oct 9, 2026 18d ago | 8-K | $1.30 $0.9002 | ▲ +30.75% | ▲ +29.26% | $0.7800 (+40.00%) |
Oct 5, 2026 22d ago | 8-K | $1.75 $1.30 | ▼ −25.71% | ▼ −26.14% | $0.7800 (−55.43%) |
Sep 24, 2026 4w ago | Press Release | $3.03 $1.87 | ▼ −38.28% | ▼ −37.87% | $0.7800 (−74.26%) |
Sep 16, 2026 5w ago | 8-K | $1.78 $2.05 | ▼ −15.17% | ▼ −12.61% | $0.7800 (+56.18%) |
Sep 15, 2026 6w ago | 8-K | $1.83 $1.91 | ▲ +4.37% | ▲ +3.55% | $0.7800 (−57.38%) |
Sep 1, 2026 8w ago | 8-K | $2.88 $2.47 | ▲ +14.24% | ▲ +14.32% | $0.7800 (+72.92%) |
Aug 31, 2026 8w ago | 8-K | $3.00 $2.88 | ▼ −4.00% | ▼ −3.86% | $0.7800 (−74.00%) |
Showing 10 of 20
US Market Status
Market Closed — Opens in 9h 10m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers